Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Eur J Surg Oncol. 2023 Nov 8;50(1):107252. doi: 10.1016/j.ejso.2023.107252

Table 1.

Comparison between baseline characteristics of MILR if the anterolateral segments in Childs A cirrhosis v non-cirrhosis

Entire unmatched cohort 1:1 PSM (nearest neighbour matching) 1:1 CEM

All (N = 3430) Child A Cirrhosis (N = 2118) Non-cirrhosis (N = 1312) P-value Child A Cirrhosis (N = 991) Non-cirrhosis (N = 991) P-value (paired) Child A Cirrhosis (N = 518) Non-cirrhosis (N = 518) P-value (paired)

Median age (IQR), yrs 64.00 [55.00, 72.00] 63.00 [55.00, 71.00] 64.00 [55.00, 73.00] 0.122 63.00 [55.00, 70.79] 64.00 [55.00, 72.00] 0.445 64.00 [56.00, 71.00] 64.00 [56.00, 71.00] 0.878

Male sex, n (%) 2468 (72.0) 1567 (74.0) 901 (68.7) 0.001 721 (72.8) 717 (72.4) 0.880 424 (81.9) 424 (81.9) NA

Median BMI (IQR) 24.60 [22.21, 27.44] 24.70 [22.24, 27.52] 24.41 [22.20, 27.25] 0.076 24.60 [22.32, 27.62] 24.30 [22.03, 26.99] 0.072 24.60 [22.21, 27.00] 24.20 [22.10, 26.82] 0.338

Robotic, n (%) 400 (11.7) 221 (10.4) 179 (13.6) 138 (13.9) 128 (12.9) 24 (4.6) 24 (4.6)
Laparoscopic, n (%) 3030 (88.3) 1897 (89.6) 1133 (86.4) 0.005 853 (86.1) 863 (87.1) 0.555 494 (95.4) 494 (95.4) NA

Previous abdominal surgery, n (%) 670 (20.2) 399 (19.8) 271 (20.8) 0.508 194 (19.6) 202 (20.4) 0.694 63 (12.2) 63 (12.2) NA

Year of surgery, n (%)
2004–2009 193 (5.6) 132 (6.2) 61 (4.6) 61 (6.2) 53 (5.3) 19 (3.7) 19 (3.7)
2010–2015 968 (28.2) 617 (29.1) 351 (26.8) 279 (28.2) 279 (28.2) 127 (24.5) 127 (24.5)
2016–2021 2269 (66.2) 1369 (64.6) 900 (68.6) 0.028 651 (65.7) 659 (66.5) 0.325 372 (71.8) 372 (71.8) NA

ASA score, n (%)
 1/2 2356 (68.7) 1454 (68.7) 902 (68.8) 688 (69.4) 682 (68.8) 391 (75.5) 391 (75.5)
 3/4 1071 (31.3) 662 (31.3) 409 (31.2) 0.987 303 (30.6) 309 (31.2) 0.807 127 (24.5) 127 (24.5) NA

Tumor type, n (%)
 HCC 3026 (88.4) 1989 (94.0) 1037 (79.5) 926 (93.4) 923 (93.1) 514 (99.2) 514 (99.2)
 ICC/ cholangiohepatoma 396 (11.6) 128 (6.0) 268 (20.5) <0.001 65 (6.6) 68 (6.9) 0.815 4 (0.8) 4 (0.8) NA

Median tumor size, mm (IQR) 29.00 [20.00, 40.00] 26.00 [20.00, 37.00] 30.00 [21.00, 45.00] <0.001 30.00 [20.00, 40.00] 30.00 [20.00, 40.00] 0.564 25.00 [20.00, 33.00] 25.00 [19.00, 35.00] 0.417

Multiple tumors, n (%) 302 (8.8) 206 (9.7) 96 (7.3) 0.019 68 (6.9) 75 (7.6) 0.597 9 (1.7) 9 (1.7) NA

Wedge/partial, n (%) 2004 (58.4) 1319 (62.3) 685 (52.2) 554 (55.9) 558 (56.3) 314 (60.6) 314 (60.6)
Segmentectomy, n (%) 1426 (41.6) 799 (37.7) 627 (47.8) <0.001 437 (44.1) 433 (43.7) 0.888 204 (39.4) 204 (39.4) NA

Concomitant minor surgery excluding cholecystectomy, n (%) 113 (3.3) 86 (4.1) 27 (2.1) 0.002 22 (2.2) 21 (2.1) 1.000 2 (0.4) 2 (0.4) NA

Hilar lymph node dissection, n (%) 112 (3.3) 9 (0.4) 103 (7.9) <0.001 9 (0.9) 13 (1.3) 0.453 1 (0.2) 1 (0.2) NA

Median Iwate difficulty score, [IQR](range) 4.00 [3.00, 6.00] (1, 9) 4.00 [2.00, 6.00] (1, 9) 4.00 [3.00, 7.00] (1, 9) <0.001 4.00 [3.00, 6.00] (1, 9) 4.00 [3.00, 6.00] (1, 9) 0.870 4.00 [3.00, 6.00] (1, 8) 4.00 [3.00, 6.00] (1, 8) NA

Iwate difficulty, n (%)
 Low 1533 (44.7) 1053 (49.7) 480 (36.6) 418 (42.2) 406 (41.0) 249 (48.1) 249 (48.1)
 Intermediate 1253 (36.6) 758 (35.8) 495 (37.8) 364 (36.7) 383 (38.6) 182 (35.1) 182 (35.1)
 High 642 (18.7) 306 (14.5) 336 (25.6) <0.001 209 (21.1) 202 (20.4) 0.856 87 (16.8) 87 (16.8) NA